A 33853

A 33853 Suppliers list
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Zhejiang Huida Biotech Co., Ltd.  
Tel: 0571-89903022 18679456698
Email: zilong@hizyme.com
A 33853 Basic information
Product Name:A 33853
Synonyms:A 33853;2-[3-HYDROXY-2-[[(3-HYDROXY-2-PYRIDINYL)CARBONYL]AMINO]PHENYL]-4-BENZOXAZOLECARBOXYLIC ACID;Antibiotic A 33853;2-(3-Hydroxy-2-(3-hydroxypicolinamido)phenyl)-benzo[d]oxazole-4-carboxylic acid;2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)-amino]-phenyl]-benzoxazole-4-carboxylic acid;4-Benzoxazolecarboxylic acid, 2-[3-hydroxy-2-[[(3-hydroxy-2-pyridinyl)carbonyl]amino]phenyl]-
CAS:80148-45-4
MF:C20H13N3O6
MW:391.33
EINECS:
Product Categories:
Mol File:80148-45-4.mol
A 33853 Structure
A 33853 Chemical Properties
Boiling point 644.9±55.0 °C(Predicted)
density 1.588±0.06 g/cm3(Predicted)
storage temp. 2-8°C
pka-2.81±0.30(Predicted)
Safety Information
MSDS Information
A 33853 Usage And Synthesis
UsesAntibiotic A-338533, an antibiotic, can be isolated from Streptomyces strain. Antibiotic A-338533 has anti-bacterial activity against Staphylococcus aureus, Mycoplasma gallisepticum with MIC values of 2 μg/mL and ≤1.56 μg/mL, respectively[1].
in vivo

Antibiotic A-33853 (60 mg/kg; s.c.; single dose) is inactive against Mycoplasma gallisepticum in chicks in vivo[1].
Antibiotic A-33853 (70 mg/kg; s.c.; twice doses) is ineffective against S. aureus in mice in vivo[1].
Antibiotic A-33853 has an acute toxic dose with a LD50 value >300 mg/kg (i.p.) on mice model[1].

References[1] In Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery of N-(2-Benzoxazol-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes J. Med. Chem., 2008, 51 (23), pp 7344-7347
[2] Michel KH, et al. The discovery, fermentation, isolation, and structure of antibiotic A33853 and its tetraacetyl derivative. J Antibiot (Tokyo). 1984 May;37(5):441-5. DOI:10.7164/antibiotics.37.441
A 33853 Preparation Products And Raw materials
Tag:A 33853(80148-45-4) Related Product Information